High-risk papillomavirus infection among women living with human Immunodeficiency virus: Brazilian multicentric study

被引:14
|
作者
Miranda, Angelica E. [1 ]
Silveira, Mariangela F. [2 ]
Travassos, Ana G. [3 ]
Tenorio, Teresinha [4 ]
Val, Isabel C. C. [5 ]
Lannoy, Leonor [6 ]
Mattos Junior, Hortensio S. [7 ]
Carvalho, Newton S. [8 ]
机构
[1] Univ Fed Espirito Santo, Vitoria, Brazil
[2] Univ Fed Pelotas, Pelotas, Brazil
[3] Univ Estadual Bahia, Salvador, BA, Brazil
[4] Univ Fed Pernambuco, Recife, PE, Brazil
[5] Univ Fed Fluminense, Niteroi, RJ, Brazil
[6] Unidade Saude Mista Asa Sul, Brasilia, DF, Brazil
[7] Lab Sao Marcos, Vila Velha, Brazil
[8] Univ Fed Parana, Curitiba, Parana, Brazil
关键词
Brazil; cervical cancer; HIV; HPV; women; INVASIVE CERVICAL-CANCER; SQUAMOUS-CELL CARCINOMA; LESIONS; HIV; PREVALENCE; PRECANCER; COUNTRIES; HIV/AIDS; DISEASE; UTILITY;
D O I
10.1002/jmv.24906
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cervical cancer is an important health issue in Latin America. Although HPV infections can have spontaneous clearance, persistence of high-risk (HR) HPV is a risk factor for cervical cancer among women and it is even higher in HIV-infected women. To determine the prevalence of HR-HPV and risk factors among HIV-infected women attending reference services for HIV/AIDS in different regions of Brazil. Cross-sectional study conducted among HIV-infected women attended at referral care centers for HIV/AIDS in nine states of Brazil. Women from 18 to 49 years that accept to participate and were not pregnant at the time of the approach were recruited for the study. The HPV screening was realized using qPCR in closed system, in vitro Diagnostic, COBAS (R)-HPV Roche. The cytology results were available by the Bethesda System. A total of 802(89.1%) from the selected women agreed to participate in the study. Median age was 39(Inter quartile range [IQR34-46]) years and median education was 9(IQR6-11) years. General prevalence of HR-HPV was 28.4%(228/802). HPV-16 prevalence rate was 8.1%(65/802), HPV-18 was 3.7%(30/802) and other types of HR-HPV were 23.6% (189/802). Risk factors for HR-HPV infection in the multivariate logistic regression analysis were: age ranging from 18 to 34 years (OR = 1.43[95%CI:1.18-1.75]), illicit drugs use (OR = 1.61[95%CI:1.10-2.42]) and abnormal cervical cytology (OR = 1.56[95%CI:1.34-1.81]). Results showed a prevalence rate of 28.4% of HR-HPV infection in women living with HIV in Brazil. These infections were significantly associated with having less than 35 years old, illicit drug use and abnormal cervical cytology.
引用
收藏
页码:2217 / 2223
页数:7
相关论文
共 50 条
  • [11] Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance Among Women in Senegal, West Africa
    Li, Zhuochen
    Winer, Rachel L.
    Ba, Selly
    Sy, Marie Pierre
    Lin, John
    Feng, Qinghua
    Gottlieb, Geoffrey S.
    Salif Sow, Papa
    Kiviat, Nancy B.
    Hawes, Stephen E.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (09) : 1088 - 1096
  • [12] Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study
    Luckett, R.
    Painter, H.
    Hacker, Mr
    Simon, B.
    Seiphetlheng, A.
    Erlinger, A.
    Eakin, C.
    Moyo, S.
    Kyokunda, L. T.
    Esselen, K.
    Feldman, S.
    Morroni, C.
    Ramogola-Masire, D.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 (12) : 1986 - 1996
  • [13] Attendance for diagnostic colposcopy among high-risk human papillomavirus positive women in a Brazilian feasibility study
    Buss, Lewis F.
    Levi, Jose E.
    Longatto-Filho, Adhemar
    Cohen, Diane D.
    Cury, Lise
    Martins, Toni R.
    Fuza, Luiz M.
    Villa, Luisa L.
    Eluf-Neto, Jose
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 152 (01) : 72 - 77
  • [14] The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus
    McClymont, Elisabeth
    Lee, Marette
    Raboud, Janet
    Coutlee, Francois
    Walmsley, Sharon
    Lipsky, Nancy
    Loutfy, Mona
    Trottier, Sylvie
    Smaill, Fiona
    Klein, Marina B.
    Harris, Marianne
    Cohen, Jeffrey
    Yudin, Mark H.
    Wobeser, Wendy
    Money, Deborah
    Alimenti, Ariane
    Azampanah, Arezou
    Bitnun, Ari
    Blitz, Sandra
    Brophy, Jason
    Christilaw, Jan
    Coldman, Andrew
    Dobson, Simon
    Hankins, Catherine
    Karatzios, Christos
    Krajden, Mel
    Lapointe, Normand
    McAlpine, Jessica
    Miller, Dianne
    Moses, Erin
    van Niekerk, Dirk
    Ogilvie, Gina
    Pick, Neora
    Samson, Lindy
    van Schalkwyk, Julie
    Scheifele, David
    Singer, Joel
    Stone, Sarah
    Stuart, Gavin
    Summers, Marcie
    Vicol, Laura
    Watt, Melissa
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (05) : 788 - 794
  • [15] Human papillomavirus infection among human immunodeficiency virus-infected women in Maharashtra, India
    Joshi, S.
    Babu, J. M.
    Jayalakshmi, D.
    Kulkarni, V.
    Divate, U.
    Muwonge, R.
    Gheit, T.
    Tommasino, M.
    Sankaranarayanan, R.
    Pillai, M. R.
    VACCINE, 2014, 32 (09) : 1079 - 1085
  • [16] Cervical Human Papillomavirus Infection (HPV) and High Oncogenic Risk Genotypes among Women Living with HIV in Asia: A Meta-Analysis
    Verrier, Florian
    Le Coeur, Sophie
    Delory, Tristan
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
  • [17] Prevalence and risk factors for high-risk human papillomavirus infection among women from three southern geopolitical zones of Nigeria
    Onwuamah, Chika Kingsley
    Feng, Ning
    Momoh, Abidemi Esther
    Uwandu, Mabel
    Ahmed, Rahaman Ademolu
    Idigbe, Ifeoma
    Vincent, Grace Deborah
    Ogbu, Chinenye Angela
    Okonkwo, Nkem
    Sokei, Judith
    Abimbola, Bowofoluwa Sharon
    Ojopagogo, Temiloluwa
    Okoli, Leona Chika
    Adesina, Mary
    Ezemelue, Priscilla Ngozi
    Sowunmi, Omowunmi
    Okwuzu, Jane
    Labo-Popoola, Olaoniye Habeebat
    Shaibu, Joseph Ojonugwa
    Ohihoin, Greg Aigbe
    Nzeribe, Emily
    David, Agatha
    Olaleye, Olufemi
    Ofotokun, Ighovwerha
    Dong, Xiao-Ping
    Ezechi, Oliver Chukwujekwu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [18] Prevalence of Anal High-Risk Human Papilloma Virus Infection and Abnormal Anal Cytology among Women Living with HIV
    Munoz-Hernando, Leticia
    Oliver-Perez, Reyes
    Bravo-Violeta, Victoria
    Olloqui, Alejandro
    Parte-Izquierdo, Belen
    Almansa-Gonzalez, Cristina
    Bermejo-Martinez, Rocio
    Bolivar-De Miguel, Ana Belen
    Diez, Alvaro
    Seoane-Ruiz, Jose Miguel
    Parrilla-Rubio, Lucia
    Tejerizo-Garcia, Alvaro
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (11):
  • [19] High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus
    Konopnicki, Deborah
    Manigart, Yannick
    Gilles, Christine
    Barlow, Patricia
    De Marchin, Jerome
    Feoli, Francesco
    Delforge, Marc
    Clumeck, Nathan
    De Wit, Stephane
    AIDS, 2016, 30 (03) : 425 - 433
  • [20] Sex Work and High-Risk Anal Human Papillomavirus Infection Among Transgender Women: The Condesa Study
    Portillo-Romero, Alejandra J.
    Allen-Leigh, Betania
    Nyitray, Alan G.
    Carnalla, Martha
    Salmeron, Jorge
    Leon-Maldonado, Leith
    Yunes, Elsa
    Rivera, Leonor
    Magis-Rodriguez, Carlos
    Vargas, Galileo
    Giuliano, Anna R.
    Esquivel-Ocampo, Eiberth A.
    Lazcano-Ponce, Eduardo
    TRANSGENDER HEALTH, 2021, 6 (06) : 315 - 324